IonQ, Inc. (NYSE:IONQ - Get Free Report) rose 21.5% on Friday following a better than expected earnings announcement. The stock traded as high as $32.62 and last traded at $32.1240. 42,375,291 shares changed hands during mid-day trading, an increase of 73% from the average session volume of 24,489,678 shares. The stock had previously closed at $26.43.
The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.35) by $0.06. IonQ had a negative return on equity of 22.29% and a negative net margin of 553.27%. The business had revenue of $173.83 million during the quarter, compared to analysts' expectations of $141.49 million. During the same period in the previous year, the business posted ($3.58) earnings per share. The firm's revenue for the quarter was up 336.0% compared to the same quarter last year.
Trending Headlines about IonQ
Here are the key news stories impacting IonQ this week:
- Positive Sentiment: IonQ reported record Q3 revenue of $173.8 million, up 336% year over year and well above analyst expectations. Its loss of $0.29 per share was also narrower than the consensus estimate of $0.35. Article
- Positive Sentiment: The company raised its full-year 2026 revenue outlook to $505 million–$515 million. Its backlog reached $1.2 billion, and Superion 256 system capacity is sold out through 2027—signals of strong demand and future revenue visibility. Article
- Positive Sentiment: IonQ also advanced to Stage C of DARPA’s quantum benchmarking initiative. The SkyWater acquisition is cited as strengthening manufacturing capabilities and contributing to the quarter’s growth. Article
- Neutral Sentiment: Cantor Fitzgerald and Needham lowered their price targets to $60 and $48, respectively, but maintained Overweight and Buy ratings. Their revisions reflect caution while still implying potential upside from the cited share price. Article
- Negative Sentiment: IonQ remains unprofitable, with a very large negative net margin. Reports also flag cash burn and potential dilution from a planned $2 billion capital raise, while commercial adoption remains uncertain. Zacks added IONQ to its Strong Sell list, highlighting a more cautious view despite the earnings beat. Article
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the company. Weiss Ratings lowered IonQ from a "sell (d+)" rating to a "sell (d-)" rating in a research report on Friday, August 21st. Wall Street Zen lowered shares of IonQ from a "sell" rating to a "strong sell" rating in a report on Saturday, August 8th. Needham & Company LLC reduced their price target on IonQ from $65.00 to $48.00 and set a "buy" rating for the company in a research report on Friday. Morgan Stanley decreased their price objective on IonQ from $49.00 to $43.00 and set an "equal weight" rating for the company in a report on Thursday, October 15th. Finally, Cantor Fitzgerald lowered their target price on shares of IonQ from $70.00 to $60.00 and set an "overweight" rating on the stock in a report on Friday. Ten analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, IonQ presently has an average rating of "Moderate Buy" and a consensus target price of $61.38.
Check Out Our Latest Report on IONQ
Insider Activity at IonQ
In other news, insider John Raymond sold 2,407 shares of IonQ stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $37.21, for a total value of $89,564.47. Following the completion of the sale, the insider directly owned 77,741 shares in the company, valued at approximately $2,892,742.61. The trade was a 3.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.55% of the company's stock.
Institutional Trading of IonQ
A number of institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in IonQ during the second quarter worth approximately $1,112,945,000. Bank of America Corp DE acquired a new position in shares of IonQ during the second quarter valued at about $344,757,000. Bank of New York Mellon Corp bought a new position in shares of IonQ during the 2nd quarter worth about $113,863,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of IonQ by 45.0% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,632,290 shares of the company's stock worth $86,936,000 after purchasing an additional 506,191 shares in the last quarter. Finally, Legal & General Group Plc acquired a new stake in shares of IonQ in the 2nd quarter valued at about $82,126,000. Institutional investors own 41.42% of the company's stock.
IonQ Stock Performance
The company has a 50 day moving average price of $37.12 and a 200 day moving average price of $41.67. The company has a market capitalization of $13.79 billion, a price-to-earnings ratio of -6.89 and a beta of 3.32.
About IonQ
(
Get Free Report)
IonQ, Inc NYSE: IONQ is a quantum computing company that develops full-stack quantum computing systems and related software. Its technology is based on trapped-ion quantum computing, which uses electrically charged atoms as qubits and is designed to support highly accurate quantum operations.
The company provides access to its quantum computers through cloud platforms and direct enterprise and research engagements. Its offerings include quantum computing hardware, cloud-based access, software tools, and professional services intended to help organizations explore applications in areas such as optimization, chemistry, materials science, artificial intelligence, and cybersecurity.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IonQ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IonQ wasn't on the list.
While IonQ currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.